Collectively, DIM alleviates hepatic lipid accumulation and oxidative stress in MASLD models through AMPK activation, subsequently modulating PPARα and SREBP1/ACC1 pathways. Here, ACACA is linked to metabolic dysfunction-associated steatotic liver disease.